According to a Vanderbilt University news release, the International Retinal Research Foundation has extended a $10 million gift to establish a center dedicated to retinal vision research at the Vanderbilt Eye Institute and a directorship to support a physician-scientist leader in the Department of Ophthalmology and Visual Sciences.
During the American Academy of Ophthalmology 2022 Annual Meeting in Chicago,Tarsus Pharmaceuticals Inc. announced the launch of the “Look at the Lids” disease education campaign for Demodex blepharitis.
Optimal performance has a limited window.
AB 2236 would have allowed optometrists to perform anterior segment laser and minor procedures which involve the use of a scalpel or injections.
Library of ViewPoint drug candidates will accelerate development of novel alpha-crystallin chaperone compounds as a non-surgical treatment for age-related cataracts.
The survey, from The Larry A. Greene Center and the Primary Care Collaborative, found that the COVID-19 pandemic has had an adverse impact on the well-being of physicians.
On this week's episode of the NeuroOp Guru, Andy Lee, MD, and Elizabeth Fortin, MD, discuss visual snow syndrome and whether it should be evaluated during standard in-clinic ophthalmologic testing.
The hour-long issue teaches the viewing ophthalmologist the technique and many modifications of intrascleral haptic fixation, an innovative approach when the capsule has been damage or is absent.
After a brief hiatus during the pandemic, the Flying Eye Hospital program returns.
The destination of Marco Island, Florida not only serves as an excellent backdrop for this year's Ophthalmology Times® EyeCon 2022 but also provides a unique opportunity for family members to see their ophthalmic loved ones in a professional light.
Let us know if you will plan to use biosimilars in your daily practice. The poll will be open until October 10, 2022.
The American Academy of Ophthalmology will hold its annual meeting beginning Friday at McCormick Place in Chicago.
The Florida Second District Court of Appeal has renewed a woman’s lawsuit claiming she suffered permanent eye damage when her ophthalmologist misdiagnosed her during nasal surgery. In its opinion, the appellate court ruled that the trial court erred when it dismissed the lawsuit.
Recent reports of retinal atrophy have raised concerns on potential long-term safety.
The advanced swept-source OCT technology allows visualization of the variations in the normal changes and those associated with aging in the posterior vitreous.
The treatment of vision problems can help improve the quality of life for many people in the city.
Jeremy Tan, MD, discusses the latest trends in eye trauma surgery at the Dean McGee Eye Institute.
NYU Langone Health has been recognized as No. 1 in quality and safety for inpatient and ambulatory care by Vizient Inc.
Co-chairs Peter J. McDonnell, MD, director of the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas in Dallas break down the top reasons to attend this year's Ophthalmology Times® EyeCon 2022 in a series of video segments.
Provectus will have an exclusive worldwide license of intellectual property developed by the Ophthalmic Biophysics Center of the Bascom Palmer Eye Institute.
The authors noted that the proportion of patients losing fewer than 15 letters from the baseline BCVA score in the study eye was comparable between the two groups.
Elizabeth Yeu, MD, will highlight pearls for managing intraocular lenses in difficult cases.
The Eye Center at UC Davis Health has two new endowed chairs focused on glaucoma, thanks to a $4 million donation from business entrepreneur Daryl Geweke.
Ophthalmologists should instruct their patients to pay attention to their eye health for the long term.
In AMD research, the experimental animals used are often young male mice. This is not optimal for the development of new treatments, as the disease most often affects the elderly – and women.
Claes H. Dohlman, MD, PhD, widely considered the father of modern cornea science, is a recipient of the 2022 António Champalimaud Vision Award. The award, considered the “Nobel Prize of Vision," comes with a $1 million prize .
According to Rishi P. Singh, MD, family history and lifestyle are key in the development of geographic atrophy.
LUNA trial will evaluate the 2x10^11 vg/eye (2E11) and a new lower 6x10^10 vg/eye (6E10) dose of Ixo-vec, with enhanced prophylactic steroid regimens in patients requiring frequent anti-VEGF injections. Interim data anticipated throughout 2023.
Heru debuts dark adaptation, the newest modality added to its wearable health and wellness platform’s vision screening line-up.
Medication is administered after LASIK and injectable prophylaxis during cataract surgery.
.png "Optometry Times"){kind=logo}
